Work

Dramatic Metabolic Response to Dual ICI With Chemotherapy in Low PD‐ L1 NSCLC Case

Year: 2025

Type: article

Abstract: Despite low PD-L1 (Programmed Death-ligand 1) expression, this patient exhibited a dramatic positron emission tomography-computed tomography response to dual immune checkpoint inhibitors with chemotherapy. This case highlights the potential benefits of combination therapy beyond traditional PD-L1-based treatment selection.

Source: Respirology Case Reports

DOI: 10.1002/rcr2.70150

Authors: Toshikazu Kumasa, Akina Nigi, Keisuke Iwamoto, Hidetoshi Itani, Shigeto Kondou

Institution: Ise Red Cross Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,130